beschikbaar?

TIP: soortgelijke CVs vinden

Turn around CEO pharma

Work Experience

CAREER HIGHLIGHTS
Current Projects
MERGER AND ACQUISITION PROGRAM (M&A)
One out of three candidates selected in the United Kingdom by Deloitte & Touche to participate in M&A program (Management Buy In ): March 1999-present
KEY ACTIVITIES
Searched and identified between 15-20 pharmaceutical acquisition targets
Led acquisition team on four separate occasions
Evaluated businesses and developed bids ranging from $ 45-160 million
Developed three comprehensive strategy and business plans for acquisition targets
Developed good working relationships with some of the world’s leading venture capital organisations
Successfully brokered acquisition of Chefaro (Akzo Nobel) by Omega Pharma in a $145 million transaction assisted by DeLoitte&Touche, corporate finance department, London, United Kingdom (January 2001)


BUSINESS ADVISOR
Phytogen Lifesciences Inc./Phytogen Pharmaceuticals Inc., Vancouver, Canada: (1998-2000)
Troponwerke (ex-Bayer), Koln, Germany (1998-2000)
Brahms Artzneimittel GmbH, Frankfurt, Germany (2001-present)
Torrent Pharma Industries, India (2002-present )
DeLoitte & Touche, Corporate Finance, London, United Kingdom (2000-present)

PRESIDENT
Wockhardt Europe Limited, Bedfordshire, UK : August 1997-March 1999
A challenging assignment to transform an Indian-based pharmaceutical industry into a multinational player in the pharmaceutical generic prescription business.
KEY ACHIEVEMENTS
Established and chaired a global new-product development team
Initiated and completed strategic alliance with Ferring Pharmaceuticals
Developed comprehensive European business strategy
Established subsidiaries in Russia and Egypt
Completed in-licensing project and regulatory strategy in Europe

MANAGING DIRECTOR
Wallis Laboratory, Bedfordshire, UK : August 1997-March 1999

Wockhardt acquired the company in 1997 with the objective to make the company profitable within the next 2 years.
KEY ACHIEVEMENTS
Revised business plan: focus on change to high margin / low volume products
Prioritised the business: 1: Cash flow, 2: Profit, 3: Sales
Established new team of directors
Increased financial visibility by introducing new computer system
Successfully managed a major business crisis (product recall: article published 1999)
Increased gross contribution percentage from 44.4 to 59 in 18 months time
Reversed significant loss situation to an estimated PBIT of £450.000 for the year 1999 (£1.000.000 for the year 2000 - ended June 30 2000)
REGIONAL BUSINESS DIRECTOR FOR CZECH & SLOVAK REPUBLICS AND HUNGARY
Pharmacia & Upjohn, Czech Republic: January 1995- April 1996
A new position created to increase the marketing sophistication in the Central European Organisations. This position is accountable for sales and earnings in the region and the development and co-ordination of country- specific business strategies and to increase marketing skills of key employees.
KEY ACHIEVEMENTS
Restructured marketing planning process
Organised and implemented marketing training classes
Supervised introduction of three new product entities
Revised plans for 1995 reversed downward trend, culminating in an 11% increase over budget for the year, with immediate increases of up to 50% for certain products.
Initiated separate marketing plans in 1996 for Czech and Slovak subsidiaries

DIRECTOR, MEDICAL SCIENCES LIAISON; EUROPE, FAR EAST AND LATIN-AMERICA
The Upjohn Company, Michigan, USA : July 1992-January 1995
A new position created to re-establish strategic, financial and operation planning processes for key markets outside the US. This position is accountable for conceptualising, co-ordinating and directing the implementation of regional marketing strategies in core business disciplines.
KEY ACHIEVEMENTS
Had a seminal role in restructuring the division’s world-wide strategic and operational planning processes
Developed and implemented regional management structure
Developed and implemented project management process for regional pre-marketing projects in Europe and Pacific Rim/Far East
Re-engineered regional budget planning process
Established excellent rapport with world-wide marketing staff; regional and subsidiary line management


REGIONAL MEDICAL SCIENCES LIAISON MANAGER: EUROPE, AFRICA AND THE MIDDLE-EAST
The Upjohn Company, Brussels, Belgium: 1989-1992

Responsible for the development and implementation of strategies and tactics required to obtain product sales goals.
KEY ACHIEVEMENTS
Successfully developed and implemented regional defensive strategies for company’s hypnotic drug
Initiated and developed formation of Pan-European management task forces to implement regional projects
Developed communication structure between home office and subsidiaries
Demonstrated excellent understanding of cultural differences and ability to work effectively in diverse environments

Education

EDUCATION

Graduate Marketing
Institute for Social Sciences the Hague, the Netherlands

Pharmacology Leiden university
Post-graduate Infectious Diseases
Leiden University , Medical School

Skills

A versatile, action-oriented executive who has delivered significant results in key line- and marketing management positions. Demonstration of sound business judgement and leadership skills. Decisiveness and well-developed planning and communication skills at consistently high levels of performance in a variety of progressively responsible and challenging international assignments.

Languages

English, German,
French and Dutch

Other

BOARD MEMBERSHIPS
Board of Directors of Phytogen Lifesciences, Vancouver B.C, Canada (1999-July 2001)
Director of Jansen Pharma Consultants Limited, Braco, Perthshire, United Kingdom


PRESENTATIONS

* “Critical Issues Facing the Modern Global Corporation”, American Graduate School of International Management, Paris, France, June 24, 1992

* “The Global Challenge Facing Corporations in the Coming Decade”, National Institutes of Health, Washington D.C. United States of America, May 1996

 beschikbaar?